Their study revealed six RMS patients among the 148 probands, and RMS was the fourth most commonly detected neoplasm amongst the DICER1 mutation carriers, behind pleuropulmonary blastoma (n = 47), Sertoli–Leydig cell tumor (n = 24), and thyroid cancer (n = 10). Here, DICER1 is linked to thyroid gland carcinoma.